Blood Transfusion Diagnostics Market Scope And Analysis

Report Code : TIPRE00005176
Category : Medical Device

Status : Published
No. of Pages : 183

Buy Now

Blood Transfusion Diagnostics Market Scope and Analysis by 2028

Buy Now

Blood Transfusion Diagnostics Market Report Scope

Report Attribute	Details
Market size in 2021	US$ 4.1 Billion
Market Size by 2028	US$ 6.48 Billion
Global CAGR (2021 - 2028)	6.9%
Historical Data	2019-2020
Forecast period	2022-2028
Segments Covered	By Product Instruments & Kits and Reagents By Application Disease Screening and Blood Grouping By End User Hospitals Diagnostic Laboratories Plasma Fractionation Companies
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Grifols S A F Hoffmann La Roche Ltd Immucor Inc Bio Rad Laboratories Inc Abbott Thermo Fisher Scientific Inc Ortho Clinical Diagnostics DiaSorin S p A Quotient Limited

End User-Based Insights

Based on end user, the global blood transfusion diagnostics market is segmented into blood banks, hospitals, diagnostic laboratories, and plasma fractionation companies. The blood banks segment held the largest market share in 2021. The same segment is expected to register the highest CAGR in the market from 2022 to 2028.

The global blood transfusion diagnostics market players take up organic strategies, including product launch and expansion, to expand their footprint and product portfolio worldwide and meet the growing demand. The key players in the market are Grifols, S.A.; F. Hoffmann-La Roche Ltd; Immucor, Inc.; Bio-Rad Laboratories, Inc.; Abbott; Thermo Fisher Scientific Inc.; Ortho Clinical Diagnostics; DiaSorin S.p.A.; Quotient Limited; and BAG Diagnostics GmbH.